Prognostic factors in HLA matched related allogeneic transplant for relapsed acute myeloid leukemia.

被引：0
|
作者：
Moulder, SL [1 ]
Arrowsmith, ER [1 ]
Stein, RS [1 ]
Goodman, SA [1 ]
Morgan, DS [1 ]
Brandt, SJ [1 ]
Greer, JP [1 ]
Wolff, SN [1 ]
机构：
[1] Vanderbilt Univ, Nashville, TN USA
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4951
引用
收藏
页码：385B / 385B
页数：1
相关论文
共 50 条
  • [21] Ethnicity as a prognostic factor for survival in acute myeloid leukemia.
    Paltiel, OB
    Alkalai, R
    Ronen, I
    Ben Yehuda, D
    BLOOD, 2001, 98 (11) : 326A - 327A
  • [22] Quantifying the survival benefit of allogeneic stem cell transplant in the management of relapsed acute myeloid leukemia
    Armistead, P. M.
    De Lima, M.
    Pierce, S.
    Giralt, S.
    Champlin, R.
    Estey, E.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 23 - 23
  • [23] Control of relapsed or refractory acute myeloid leukemia by clofarabine in preparation for allogeneic stem cell transplant
    Loeffler, Claudia
    Kapp, Markus
    Grigoleit, Goetz-Ulrich
    Mielke, Stephan
    Loeffler, Juergen
    Heuschmann, Peter U.
    Malzahn, Uwe
    Hupp, Elke
    Einsele, Hermann
    Stuhler, Gernot
    LEUKEMIA & LYMPHOMA, 2015, 56 (12) : 3365 - 3369
  • [24] Prognostic factors in acute myeloid leukemia
    Avivi, I
    Rowe, JM
    CURRENT OPINION IN HEMATOLOGY, 2005, 12 (01) : 62 - 67
  • [25] Treatment of relapsed and refractory acute myeloid leukemia with a salvage FLAG-IDA chemotherapy regimen followed by a HLA matched related allogeneic PBSC infusion without additional conditioning
    Chandy, Mammen
    Mathews, Vikram
    Rajeskar, T.
    Viswabandya, Auro
    Lakshmi, Kavitha M.
    John, Joseph M.
    George, Biju
    Srivastava, Alok
    BLOOD, 2007, 110 (11) : 342B - 342B
  • [26] IDH inhibitors or chemotherapy in relapsed or refractory IDHmut acute myeloid leukemia.
    Murray, Graeme
    Bouligny, Ian Michael
    Patel, Tilak
    Doyel, Michael
    Boron, Josh
    Tran, Valerie
    Gor, Juhi
    Hang, Yiwei
    Ho, Thuy
    Zacholski, Kyle
    Venn, Chad Michael
    Alnimer, Yanal Mufeed
    Wages, Nolan
    Grant, Steven
    Maher, Keri Renee
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [27] Pharmacokinetics and pharmacodynamics of gilteritinib in patients with relapsed or refractory acute myeloid leukemia.
    Smith, Catherine Choy
    Levis, Mark J.
    Litzow, Mark Robert
    Perl, Alexander E.
    Altman, Jessica K.
    Gill, Stan
    Yuen, Geoffrey
    Bonate, Peter
    Kadokura, Takeshi
    James, Angela Joubert
    Liu, Charles
    Nagase, Itsuro
    Fisniku, Ogert
    Bahceci, Erkut
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [28] PROGNOSTIC FACTORS IN RELAPSED ACUTE NONLYMPHOCYTIC LEUKEMIA
    UHLMAN, DL
    BLOOMFIELD, CD
    HURD, DD
    PETERSON, BA
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 210 - 210
  • [29] Prognostic relevance of immunophenotype in 379 patients with acute myeloid leukemia.
    Chang, H
    Salma, F
    Yi, QI
    Patterson, BJ
    Brien, B
    Wells, R
    Schuh, A
    Brandwein, J
    Minden, MD
    BLOOD, 2002, 100 (11) : 256B - 256B
  • [30] The relative prognostic importance of hyperleukocytosis on outcome in acute myeloid leukemia.
    Greenwood, MJ
    Seftel, MD
    Guan, YH
    Barbaric, D
    Ainsworth, L
    Sutherland, HJ
    Nevill, TJ
    Nantel, SH
    Toze, CL
    Hogge, DE
    BLOOD, 2002, 100 (11) : 335A - 335A
12345